Literature DB >> 6234266

Alloproliferative human T cell clones primed and cultured in vitro lose proliferative and gain suppressive activity with age.

G Pawelec, P Wernet, A Rehbein, I Balko, E M Schneider.   

Abstract

Alloreactive human T lymphocyte clones were found to lose antigen-stimulated proliferative capacity and their ability to secrete interleukin 2 (IL 2) after a critical period in tissue culture. Instead, they gained the previously absent capacity to suppress lymphoproliferative (LP) responses in the presence or absence of exogenous IL 2. Such "ex-PLT" suppressive clones continued to grow perfectly well, retaining IL 2 and filler cell dependency, apparently normal karyotypes, and their OKT4+, OKT8- phenotypes. At least two suppressive mechanisms were demonstrated: (1) the "induction" of suppressive effectors in normal peripheral lymphocytes, and (2) a direct suppressive activity on lymphocyte proliferation shown by their ability to inhibit restimulation of cloned lymphocytes lacking suppressor cell precursors. The consistent "differentiation" from IL 2-secreting "helper" status to nonspecific suppressive status may represent a novel immunoregulatory phase in the long-term differentiation of normal human T cells.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6234266     DOI: 10.1016/0198-8859(84)90079-x

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  2 in total

1.  Functionally distinct human T-lymphocyte clones sharing potent suppressive activity on immunoglobulin secretion.

Authors:  F Falcioni; G Pawelec; N Brattig; E M Schneider; P Berg; P Wernet
Journal:  Immunology       Date:  1985-04       Impact factor: 7.397

2.  Persistence of decreased T-helper cell function in industrial workers 20 years after exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin.

Authors:  T Tonn; C Esser; E M Schneider; W Steinmann-Steiner-Haldenstätt; E Gleichmann
Journal:  Environ Health Perspect       Date:  1996-04       Impact factor: 9.031

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.